Cy­ber­se­cu­ri­ty ex­perts warn bio­phar­ma in­dus­try is not pre­pared for the next big at­tack: 'We are thor­ough­ly f****d'

The bio­phar­ma in­dus­try cel­e­brat­ed a win on the cy­ber­se­cu­ri­ty front this week, with Mer­ck emerg­ing vic­to­ri­ous from its years-long le­gal bat­tle with in­sur­ers over the cov­er­age of dev­as­tat­ing loss­es from a 2017 ran­somware at­tack. But on the heels of that vic­to­ry, ex­perts warn that the in­dus­try has left its doors wide open for fu­ture at­tacks.

Ear­li­er this week, the De­part­ment of Home­land Se­cu­ri­ty re­port­ed­ly sent a bul­letin to law en­force­ment agen­cies warn­ing of more po­ten­tial Russ­ian cy­ber­at­tacks as ten­sions rise over con­flict with Ukraine, ac­cord­ing to ABC News. Britain’s Na­tion­al Cy­ber Se­cu­ri­ty Cen­tre al­so is­sued a state­ment on Fri­day urg­ing UK busi­ness­es to bol­ster their cy­ber­se­cu­ri­ty.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN